18 results for author:"Mikulits W." in Literature citations
Results Customize
› Repeat search in UniProtKB (5)
| M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues. Puxbaum V., Nimmerfall E., Bauerl C., Taub N., Blaas P.M., Wieser J., Mikula M., Mikulits W., Ng K.M., Yeoh G.C. et al. J. Hepatol. 57:337-343(2012) · Mapped (12) |
| NF-kappaB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells. Vonach C., Viola K., Giessrigl B., Huttary N., Raab I., Kalt R., Krieger S., Vo T.P., Madlener S., Bauer S. et al. Br. J. Cancer 105:263-271(2011) · Mapped (1) |
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. Kerjaschki D., Bago-Horvath Z., Rudas M., Sexl V., Schneckenleithner C., Wolbank S., Bartel G., Krieger S., Kalt R., Hantusch B. et al. J. Clin. Invest. 121:2000-2012(2011) · Mapped (2) |
| p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma. Schneller D., Machat G., Sousek A., Proell V., van Zijl F., Zulehner G., Huber H., Mair M., Muellner M.K., Nijman S.M. et al. Hepatology 54:164-172(2011) · Mapped (14) |
| Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. Lagger S., Meunier D., Mikula M., Brunmeir R., Schlederer M., Artaker M., Pusch O., Egger G., Hagelkruys A., Mikulits W. et al. EMBO J. 29:3992-4007(2010) · Mapped (10) |
| The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential. El-Gazzar A., Wittinger M., Perco P., Anees M., Horvat R., Mikulits W., Grunt T.W., Mayer B., Krainer M. Gynecol. Oncol. 117:451-459(2010) · Mapped (5) |
| Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Mair M., Zollner G., Schneller D., Musteanu M., Fickert P., Gumhold J., Schuster C., Fuchsbichler A., Bilban M., Tauber S. et al. Gastroenterology 138:2499-2508(2010) · Mapped (7) |
| BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment. Pils D., Wittinger M., Petz M., Gugerell A., Gregor W., Alfanz A., Horvat R., Braicu E.I., Sehouli J., Zeillinger R. et al. Gynecol. Oncol. 117:189-197(2010) · Mapped (4) |
| Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Blaas L., Kornfeld J.W., Schramek D., Musteanu M., Zollner G., Gumhold J., van Zijl F., Schneller D., Esterbauer H., Egger G. et al. Hepatology 51:1319-1326(2010) · Mapped (17) |
| Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Zulehner G., Mikula M., Schneller D., van Zijl F., Huber H., Sieghart W., Grasl-Kraupp B., Waldhor T., Peck-Radosavljevic M., Beug H. et al. Am. J. Pathol. 176:472-481(2010) · Mapped (9) |
| The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells. Probst O.C., Puxbaum V., Svoboda B., Leksa V., Stockinger H., Mikula M., Mikulits W., Mach L. Int. J. Cancer 124:2559-2567(2009) · Mapped (12) |
| ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Lahsnig C., Mikula M., Petz M., Zulehner G., Schneller D., van Zijl F., Huber H., Csiszar A., Beug H., Mikulits W. |
| Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Sutterluty H., Mayer C.E., Setinek U., Attems J., Ovtcharov S., Mikula M., Mikulits W., Micksche M., Berger W. Mol. Cancer Res. 5:509-520(2007) · Mapped (12) |
| The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression. Aigner K., Descovich L., Mikula M., Sultan A., Dampier B., Bonne S., van Roy F., Mikulits W., Schreiber M., Brabletz T. et al. FEBS Lett. 581:1617-1624(2007) · Mapped (2) |
| The plasticity of p19 ARF null hepatic stellate cells and the dynamics of activation. Proell V., Mikula M., Fuchs E., Mikulits W. Biochim. Biophys. Acta 1744:76-87(2005) · Mapped (3) |
| beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Eger A., Stockinger A., Park J., Langkopf E., Mikula M., Gotzmann J., Mikulits W., Beug H., Foisner R. Oncogene 23:2672-2680(2004) · Mapped (3) |
| hNMP 200: a novel human common nuclear matrix protein combining structural and regulatory functions. Gotzmann J., Gerner C., Meissner M., Holzmann K., Grimm R., Mikulits W., Sauermann G. Exp. Cell Res. 261:166-179(2000) · UniProtKB (1) · Mapped (1) |
| Structure and function of the iron-responsive element from human ferritin L chain mRNA. Mikulits W., Sauer T., Infante A.A., Garcia-Sanz J.A., Mullner E.W. Biochem. Biophys. Res. Commun. 235:212-216(1997) · UniProtKB (1) |